7. Stockholders' Equity |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Notes | |
| 7. Stockholders' Equity | 7. Stockholders’ Equity
Common Stock
The Company is authorized to issue 495,000,000 shares of common stock.
Preferred Stock
Series A Preferred Stock
The Company is authorized to issue 5,000,000 Series A Preferred Stock at a par value of $0.001 per share. Each share is entitled to one (1) vote, is not convertible into common stock, but have liquidation preference of $1.00 per share, plus any declared but unpaid dividends.
Each share of Series A Preferred Stock entitles the holder to receive, if and when declared by the Board of Directors, one (1) share of common stock per annum as a dividend, provided the holder owns the share on November 25 of the applicable year. The dividend is non-cumulative and payable solely in common stock. For the year ended December 31, 2025 no dividend was declared.
The Series A Preferred Stock may be redeemed, at the option of the Company, at any time on or before October 25, 2034, by issuing ten (10) shares of common stock for each one (1) share of Series A Preferred Stock outstanding. As of June 30, 2026 and December 31, 2025, no redemptions have been declared or effected.
Securities Issuances
Stock payable at June 30, 2026 and December 31, 2025 consists of preferred shares and restricted common shares owed to members of the board of directors for directors’ fees and contract services. These shares were valued at $1,146,875 and $1,053,125, respectively based on the fair value of the Company’s common stock at the date of board authorization. An additional amount of common shares are owed to various non-related vendors at June 30, 2026 and December 31, 2025 valued at $437,922 and $362,922 based on the fair value of the Company’s common stock at the date of board authorization.
During the year ended December 31, 2025, 843,941 shares of common stock were issued to convert $10,831 of a note payable, $-0- of accrued interest and $1,457 of fees. The note was converted at an applicable conversion rate of $0.014560. Market value at date of conversion was $0.0343 which produced a loss on debt settlement of $16,700.
During the year ended December 31, 2025 the Company issued 4,200,000 shares of common stock in exchange for 420,000,000 Dogecoin Cash Tokens.
During the year ended December 31, 2025 the Company issued 3,968,254 shares of common stock for services that were previously recorded in stock payable valued at $62,500.
During the year ended December 31, 2025 the Company issued 7,192,913 shares of common stock for exercised cashless warrants valued at $26,578.
Stock Compensation Plans
2020 Stock Plan
On September 25, 2020, the Company adopted the Cannabis Sativa 2020 Stock Plan which authorized the Company to utilize common stock to compensate employees, officers, directors, and independent contractors for services provided to the Company. By resolution dated September 25, 2020, the Company authorized up to 1,000,000 shares of common stock to be issued pursuant to the 2020 Stock Plan. This amount was subsequently increased to 2,000,000 shares on January 27, 2021. At June 30, 2026 and December 31, 2025, 44,425 shares were available for future issuance. |